Panelist Profile

 

Takeshi Komatani

Shusaku Yamamoto , Patent Attorney (JP)

 

Takeshi S Komatani is currently a firm’s principal of the chemical/pharma and bio/life sciences groups, and have a number of counsels including academia, start-ups, and big pharma in Japanese and non-Japanese entities.

Takeshi received his PhD from the University of Tokyo, Japan, and qualified as a Japanese pharmacist (chemist) with a certificate of Kampo and natural medicines specialist qualification. He was a researcher at F Hoffmann-La Roche in Basle, Switzerland. Thereafter, he joined Shusaku Yamamoto, an IP and law firm in Osaka, Japan, in 1998, and was registered to practise before the JPO and appear as patent and trademark counsel before the Japanese courts, admitted in 2000. He was registered as an IP litigation certified attorney before the Japanese courts in 2004. He has completed the EU-recognised PharmaTrain course (CoE equivalent to master's degree) in 2017.?He also received LL.B. from Keio University in 2019.  In 2019, he has also been qualified as a Board Certified Member of the Japanese Association of Pharmaceutical Medicine, which is equivalent to having completed CPI (Certified Physician Investigator) accredited by ACRP (Association of Clinical Research Professionals).

He is a member of AIPPI and Vice Chair of TRIPS standing committee since 2018, and a member of the editorial board of the Pharmaceutical Patent Analyst (UK) since 2012. He is also a member of JPAA, APAA, IPAJ, PSJ, JPA, AAAS. He has lectured, and contributed a number of articles, extensively on Japanese and international/trilateral IP and pharma law/practice.  He also gives lectures at a number of academic institutions including Kyoto University, Osaka University, Doshisha University, Shiga University of Medicine, Oita University, Keio University, Kwansei University and the like.